Pale Prospects for Palsy: Boy suffering cerebral palsy got chance at unique treatment thanks to his own cord blood.
CBC Group is pleased to announce that as of today, we have passed another milestone. After issuing cord blood for 17 patients so far, now, for the first time, the CBC Group has released autologous cord blood of its client for use in experimental medicine to aid in the treatment of Cerebral Palsy.
Cerebral Palsy is a condition causing severe motor conditions which are resulting in physical disability in human development. To date, no treatment is known. Our client, 2 year old boy, suffering from this disease, was given a rare and unique opportunity. He was selected as one of the patients for the most renowned clinical study at the prestigious Duke University, which focuses on the impact of administering autologous cord blood to children with Cerebral Palsy. This study is conducted by Dr. Kurtzberg, one of the world’s leading experts in the field of cord blood transplantations. Preliminary results of the study are more than promising. The final results are highly anticipated and hold great potential for using autologous cord blood in aiding the Cerebral Palsy treatment.
The Cord Blood Center Group is one of the leading private cord blood banks offering services across Europe. Since 1999 the Cord Blood Center Group has been running its own processing and storage facilities. The Cord Blood Center Group enables parents to bank their child's cord blood in a family bank for future medical use or to donate it to a public bank. Donated cord blood is available for treatment of unrelated patients worldwide by means of international cooperation.
The Cord Blood Center Group has released the cord blood unit for the 1st autologous cord blood transplantation in Europe for a baby boy suffering medulloblastoma.
Back to Press News